{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:25:13Z","timestamp":1763443513317,"version":"3.45.0"},"reference-count":38,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["R35GM151996"],"award-info":[{"award-number":["R35GM151996"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Coronaviruses include various strains that reside in natural animal reservoirs, with zoonotic transmission posing risks to both domesticated animals and human health. Recent efforts to address coronavirus infections have focused on developing inhibitors targeting the main protease (Mpro), some of which exhibit potential broad-spectrum efficacy. This study presents crystal structures of four clinically relevant inhibitors\u2014GC376, PF-00835231, nirmatrelvir, and ibuzatrelvir\u2014bound to Mpro from the feline coronavirus strain FECV-UU23. Structural analysis identified distinct FECV-specific features within the active site where these inhibitors bind and revealed S4 loop as a susceptible structural region essential for the enhanced binding of inhibitors in UU23 Mpro. We therefore propose to incorporate sterically constrained, functionally tailored heterocyclic moieties at the P3 site of known inhibitors which can optimally engage Q187, P188, and S189 residues of the S4 loop. The findings presented enhance understanding of inhibitor specificity and reinforce the promise of these inhibitor scaffolds for developing antivirals against feline coronavirus strains, with possible applications in broad-spectrum coronavirus therapy.<\/jats:p>","DOI":"10.3390\/v17111506","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:04:07Z","timestamp":1763388247000},"page":"1506","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural Analysis of Inhibitor Binding to the Feline Enteric Coronavirus (FECV) Main Protease"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5479-2029","authenticated-orcid":false,"given":"Arooma","family":"Maryam","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8696-4315","authenticated-orcid":false,"given":"Stephanie A.","family":"Moquin","sequence":"additional","affiliation":[{"name":"Biomedical Research, Novartis, Emeryville, CA 94608, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dustin","family":"Dovala","sequence":"additional","affiliation":[{"name":"Biomedical Research, Novartis, Emeryville, CA 94608, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4771-804X","authenticated-orcid":false,"given":"Jagroop","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5036-676X","authenticated-orcid":false,"given":"Nese","family":"Kurt Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6994-2416","authenticated-orcid":false,"given":"Ala M.","family":"Shaqra","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2270-6613","authenticated-orcid":false,"given":"Celia A.","family":"Schiffer","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and Sources of Endemic Human Coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv. Virus Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: Implications for SARS-CoV-2","volume":"19","author":"Kratzel","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rvsc.2020.12.023","article-title":"Mutation analysis of the spike protein in Italian feline infectious peritonitis virus and feline enteric coronavirus sequences","volume":"135","author":"Decaro","year":"2021","journal-title":"Res. Vet. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-020-2334-5","article-title":"Infection of dogs with SARS-CoV-2","volume":"586","author":"Sit","year":"2020","journal-title":"Nature"},{"key":"ref_6","first-page":"295","article-title":"SARS-CoV-2 transmission from infected owner to household dogs and cats is associated with food sharing","volume":"122","author":"Calderon","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_7","unstructured":"(2025, May 01). Pet Ownership and Demographics Sourcebook AVMA 2022. Available online: https:\/\/ebusiness.avma.org\/files\/ProductDownloads\/eco-pet-demographic-report-22-low-res.pdf."},{"key":"ref_8","first-page":"004","article-title":"Human Respiratory Coronaviruses Detected In Patients with Influenza-Like Illness in Arkansas, USA","volume":"2014","author":"Silva","year":"2014","journal-title":"Virol. Mycol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"199059","DOI":"10.1016\/j.virusres.2023.199059","article-title":"An updated review of feline coronavirus: Mind the two biotypes","volume":"326","author":"Gao","year":"2023","journal-title":"Virus Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Pearson, M., LaVoy, A., Evans, S., Vilander, A., Webb, C., Graham, B., Musselman, E., LeCureux, J., VandeWoude, S., and Dean, G.A. (2019). Mucosal immune response to feline enteric coronavirus infection. Viruses, 11.","DOI":"10.3390\/v11100906"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.aivir.2016.08.002","article-title":"Feline coronaviruses: Pathogenesis of feline infectious peritonitis","volume":"96","author":"Tekes","year":"2016","journal-title":"Adv. Virus Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s00705-005-0598-6","article-title":"Replication of feline coronaviruses in peripheral blood monocytes","volume":"150","author":"Dewerchin","year":"2005","journal-title":"Arch. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/vetr.3143","article-title":"Concerning feline infectious peritonitis outbreak in Cyprus","volume":"192","author":"Attipa","year":"2023","journal-title":"Vet. Rec."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1098612X231194460","DOI":"10.1177\/1098612X231194460","article-title":"Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020\u20132022)","volume":"25","author":"Taylor","year":"2023","journal-title":"J. Feline Med. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"113584","DOI":"10.1016\/j.ejmech.2021.113584","article-title":"Improved SARS-CoV-2 M(pro) inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies","volume":"222","author":"Vuong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lu, J., Chen, S.A., Khan, M.B., Brassard, R., Arutyunova, E., Lamer, T., Vuong, W., Fischer, C., Young, H.S., and Vederas, J.C. (2022). Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition. Front. Chem., 10.","DOI":"10.3389\/fchem.2022.852210"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lockbaum, G.J., Reyes, A.C., Lee, J.M., Tilvawala, R., Nalivaika, E.A., Ali, A., Kurt Yilmaz, N., Thompson, P.R., and Schiffer, C.A. (2021). Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188. Viruses, 13.","DOI":"10.3390\/v13020174"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zvornicanin, S.N., Shaqra, A.M., Huang, Q.J., Ornelas, E., Moghe, M., Knapp, M., Moquin, S., Dovala, D., Schiffer, C.A., and Kurt Yilmaz, N. (2023). Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses. Viruses, 15.","DOI":"10.1101\/2023.02.01.526623"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Noske, G.D., de Souza Silva, E., de Godoy, M.O., Dolci, I., Fernandes, R.S., Guido, R.V.C., Sj\u00f6, P., Oliva, G., and Godoy, A.S. (2023). Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2023.103004"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1021\/jacsau.4c00508","article-title":"A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (Mpro) of SARS-CoV-2 and MERS-CoV","volume":"4","author":"Chen","year":"2024","journal-title":"JACS Au"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: A comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/355472a0","article-title":"Free R value: A novel statistical quantity for assessing the accuracy of crystal structures","volume":"355","year":"1992","journal-title":"Nature"},{"key":"ref_25","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Petersson, G.A., and Nakatsuji, H. (2016). Gaussian 16 Rev. C.01, Gaussian, Inc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"electronic Ligand Builder and Optimization Workbench (eLBOW): A tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: Model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"W375","DOI":"10.1093\/nar\/gkm216","article-title":"MolProbity: All-atom contacts and structure validation for proteins and nucleic acids","volume":"35","author":"Davis","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bell, J., Cao, Y., Gunn, J., Day, T., Gallicchio, E., Zhou, Z., Levy, R., and Farid, R. (2012). PrimeX and the Schr\u00f6dinger computational chemistry suite of programs. International Tables for Crystallography, Wiley.","DOI":"10.1107\/97809553602060000864"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated Modeling Program, Applied Chemical Theory (IMPACT)","volume":"26","author":"Banks","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: Consistent treatment of internal and surface residues in empirical p K a predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"ref_32","first-page":"82","article-title":"Pymol: An open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/JVI.02531-09","article-title":"Evaluating the substrate-envelope hypothesis: Structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance","volume":"84","author":"Nalam","year":"2010","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1038\/s41467-022-31210-w","article-title":"Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance","volume":"13","author":"Shaqra","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1021\/acsinfecdis.3c00560","article-title":"Contributions of hyperactive mutations in Mpro from SARS-CoV-2 to drug resistance","volume":"10","author":"Flynn","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e00872-20","DOI":"10.1128\/AAC.00872-20","article-title":"Discovery of M Protease Inhibitors Encoded by SARS-CoV-2","volume":"64","author":"Hung","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Chen, W., Shao, Y., Peng, X., Liang, B., Xu, J., and Xing, D. (2022). Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1035969"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/11\/1506\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:22:36Z","timestamp":1763443356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/11\/1506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["v17111506"],"URL":"https:\/\/doi.org\/10.3390\/v17111506","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2025,11,16]]}}}